Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lu AF35700 single- and multiple-dose tolerability and pharmacokinetics study in healthy young men
NL-OMON37766Active, not recruiting
- Sponsor
- Lundbeck
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of lu af35700 in mental disorder, sponsored by Lundbeck. Primary endpoint: Safety and tolerability. Started Apr 2012; status: active, not recruiting.
02
Drugs
lu af35700
03
Conditions
mental disorder
Beyond the preview
Go deeper on NL-OMON37766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37766.